APA (7th ed.) Citation

Biswas, M., Murad, M. A., Ershadian, M., Kali, M. S. K., & Sukasem, C. (2025). Risk of major adverse cardiovascular events in CYP2C19LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta‐analysis. CTS: Clinical & Translational Science, 18(2), 1. https://doi.org/10.1111/cts.70080

Chicago Style (17th ed.) Citation

Biswas, Mohitosh, Murshadul Alam Murad, Maliheh Ershadian, Most Sumaiya Khatun Kali, and Chonlaphat Sukasem. "Risk of Major Adverse Cardiovascular Events in CYP2C19LoF Genotype Guided Clopidogrel Against Alternative Antiplatelets for CAD Patients Undergoing PCI: Meta‐analysis." CTS: Clinical & Translational Science 18, no. 2 (2025): 1. https://doi.org/10.1111/cts.70080.

MLA (9th ed.) Citation

Biswas, Mohitosh, et al. "Risk of Major Adverse Cardiovascular Events in CYP2C19LoF Genotype Guided Clopidogrel Against Alternative Antiplatelets for CAD Patients Undergoing PCI: Meta‐analysis." CTS: Clinical & Translational Science, vol. 18, no. 2, 2025, p. 1, https://doi.org/10.1111/cts.70080.